The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism - Top-Institutions - MDSpire

The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

  • By

  • Angela Bronte

  • Elena Prieto

  • Gemma Quincoces

  • Elena Erro

  • Javier Arbizu

  • February 6, 2025

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neuroimaging
    • Neurology
    • Nuclear Medicine

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Nuclear Medicine

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neuroimaging
    • Nuclear Medicine

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Nuclear Medicine
    • Neuroimaging

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Neuroimaging
    • Neurology
    • Nuclear Medicine

Original Source(s)

The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

  • by Angela Bronte, Elena Prieto, Gemma Quincoces, Elena Erro, Javier Arbizu

  • February 6, 2025

Related Content

The duality of disease: the Alzheimer’s disease dilemma through the lens of nosos and asthenia

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min
Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation